We’re delighted to announce that Morningside is a Major Partner of the British Science Festival 2022, which this year is being hosted at De Montfort University.
The annual festival is close to our hearts at Morningside because our company has grown from investment in innovation, Research & Development and continuous improvement.
Over the past 30 years we have taken an approach unique for a pharmaceuticals manufacturer and supplier; and are proud to be able to offer pharmacists and patients’ greater choice. Today we have over 302 marketing authorisations in the UK and globally.
Morningside is also passionate about promoting education, skills and preparing young people for the world of work.
The Festival features more than 100 events showcasing some of the most exciting, impactful and inspirational research happening in the host city Leicester and across the UK.
This year’s theme is ‘Connections’ which is focused on celebrating togetherness, after a period of isolation following the Covid lockdowns of 2020 and 2021.
However, as well as exploring the importance and joy in connections between individual scientists, research groups and institutions, visitors also discovered the different ways connections appear across all areas of science.
A spokesperson from the festival said: “The connection between human actions and climate change is a fantastic topic to explore. Or how about how atoms connect to form chemical bonds which make up everything around us. What is water if not a connection between hydrogen and oxygen?
“The human body is another topic that offers a plethora of opportunities to think about connections. Why not use how our organs are connected and work together as a brilliant topic to learn.”
There was also a keen focus on innovations in science, technology, engineering and maths, which are built on connections between people.
For Morningside the theme of ‘Connections’ has been a key part of the business’ innovative strategy, which is to manage the entire end-to-end process from Research & Development, to registration, to sales, marketing and export within the company.
We develop and launch a wide-range of niche generic medicines, which offer new novel ways for patients to take their medication.
Over the past 15 years the business has been the first and second to launch a generic product in the UK on over 72 occasions. This includes becoming the first to launch the generic version of the contraceptive pill (Microgynon) in the UK, in 2010.
To find out more about the British Science Festival visit here.
